All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 59 of 206 pages ‹ First < 57 58 59 60 61 > Last ›
HSL13240
  Smith A.
 Big Pharma opens wallet to Dems
 CNNMoney.com 2008 Mar 7
 
http://money.cnn.com/2008/03/04/news/companies/pharma_votes/
HSL13012
  Hirschler B.
 Drug test laws to be tightened after Glaxo probe
 Reuters 2008 Mar 6
 
http://uk.reuters.com/article/hotStocksNews/idUKL0680920020080306?rpc=401&feedType=RSS&feedName=hotStocksNews&rpc=401
HSL13013
 GSK investigation concludes
 MHRA 2008 Mar 6
 
http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON014153
HSL13015
  Hodgson M, Watt N.
 Drugs firms face new laws on test results
 The Guardian 2008 Mar 6
 
http://www.guardian.co.uk/science/2008/mar/06/medicalresearch.drugspolicy
HSL13065
 Pfizer CEO Speaks
 CNBC 2008 Mar 6
 
http://www.cnbc.com/id/15840232?play=1&video=674515585&__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&par=yahoo
HSL13067
  Joling D.
 Alaska blasts Zyprexa labeling at Lilly trial
 The Indianapolis Star 2008 Mar 6
 
http://www.indystar.com/apps/pbcs.dll/article?AID=/20080306/BUSINESS/803060512/0/LOCAL
HSL13068
 Goldstein J.
 U.K. to Tighten Pharma Rules as Glaxo Avoids Prosecution
 The Wall Street Journal 2008 Mar 6
 
http://blogs.wsj.com/health/2008/03/06/uk-to-tighten-pharma-rules-as-glaxo-avoids-prosecution/?mod=yahoo_hs
HSL13070
 Huckman M.
 FDA Turns Over Dendreon Documents - Here They Are
 Seeking Alpha 2008 Mar 6
 
http://seekingalpha.com/article/67390-fda-turns-over-dendreon-documents-here-they-are?source=feed
HSL13071
 Compulsory licensing gives the poor access to medicines, but at risk of trade sanctions 
 The Nation 2008 Mar 6
 
HSL13072
  Wiriyapong N.
 Bayer lashes out against compulsory licences
 Bangkok Post 2008 Mar 6
 
HSL13075
 Doctors On The Take
 The Hartford Courant 2008 Mar 6
 
http://www.courant.com/news/opinion/editorials/hc-bigpharma.artmar06,0,5231823.story
HSL13080
 Young A.
 First Autism-Vaccine Link: How Hannah Made History
 The Atlanta Journal-Constitution 2008 Mar 6
 
http://www.ajc.com/metro/content/printedition/2008/03/06/autism0306b.html
HSL13082
 GSK denies withholding data about Seroxat
 PM Live 2008 Mar 6
 
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6550
HSL13086
 Drug Makers Increased Prices By Average Of 7.4% In 2007 For Medications Most Commonly Prescribed To Elderly, AARP Study Finds
 Medical News Today 2008 Mar 6
 
http://www.medicalnewstoday.com/articles/99617.php
HSL13097
 Kalisch LM, Roughead EE, Gilbert AL.
 Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia
 Pharmacoepidemiol Drug Saf. 2008 March 6;
 
http://www3.interscience.wiley.com/cgi-bin/abstract/117929304/ABSTRACT?CRETRY=1&SRETRY=0
HSL13114
  Demer L.
 State claims drug maker hid data
 Anchorage Daily News 2008 Mar 6
 
http://www.adn.com/front/story/336455.html
HSL13117
  Goldstein S.
 Glaxo escapes prosecution on Seroxat disclosure
 MarketWatch 2008 Mar 6
 
http://www.marketwatch.com/news/story/glaxo-escapes-prosecution-depression-drug/story.aspx?guid=%7B3689F3DC-6EE8-4750-ADAC-B65AFFA63833%7D
HSL13137
  Silverman E.
 Congress Eyes Psychotropics & Foster Care Kids
 Pharmalot 2008 Mar 6
 
http://www.pharmalot.com/2008/03/congress-eyes-psychotropics-foster-care-kids/
HSL12975
  Girion L.
 Botox maker under investigation
 Los Angeles Times 2008 Mar 5
 
http://www.latimes.com/business/la-fi-botox5mar05,1,3879300.story
HSL13004
  Smith P.
 Sponsored education: the debate rages on
 Australian Doctor 2008 Mar 5
 
http://www.australiandoctor.com.au/articles/F8/0C0548F8.asp
HSL13009
 In praise of ... placebos
 The Guardian 2008 Mar 5
 
http://www.guardian.co.uk/commentisfree/2008/mar/05/medicalresearch?gusrc=rss&feed=science
HSL13010
  Demer L.
 Millions of dollars at stake in Zyprexa trial
 Anchorage Daily News 2008 Mar 5
 
http://www.adn.com/life/story/335336.html
HSL13060
 Perrone M.
 Blockbuster medication worries prompt probe
 San Francisco Chronicle 2008 Mar 5
 
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/03/05/BUPSVDDEV.DTL
HSL13063
 Corbett Dooren J.
 Cancer Risk Rises Slightly After Hormone Therapy Ends
 The Wall Street Journal 2008 Mar 5
 
http://online.wsj.com/article/SB120466125045011067.html?mod=yahoo_hs&ru=yahoo
HSL13064
 Carey B.
 More Expensive Placebos Bring More Relief
 The New York Times 2008 Mar 05
 
http://www.nytimes.com/2008/03/05/health/research/05placebo.html?bl&ex=1204866000&en=3ad7709984fe3164&ei=5087%0A
HSL13066
 Fay Cortez M.
 Drug Prices Fool Patients About Benefits, Placebo Study Shows 
 Bloomberg.com 2008 Mar 5
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=aAmdWrOf6gl0&refer=healthcare
HSL13069
 Corbett Dooren J.
 FDA: Seeking Additional Information On Asthma Drugs
 CNNMoney.com 2008 Mar 5
 
http://money.cnn.com/news/newsfeeds/articles/djf500/200803051444DOWJONESDJONLINE001045_FORTUNE5.htm
HSL13119
  Mansell P.
 Sea change unlikely on unpublished trial data 
 Pharma Times 2008 Mar 5
 
http://www.pharmatimes.com/clinicalnews/article.aspx?id=13006&src=EWorldNews
HSL13138
  Taylor L.
 DTC ads work, and not just for advertised drugs, says study 
 Pharma Times 2008 Mar 5
 
http://www.pharmatimes.com/worldnews/article.aspx?id=13009&src=EWorldNews
HSL13149
 Steinbrook R.
 Financial Support of Continuing Medical Education
 JAMA 2008 Mar 5;299:(9):1060-1062
 
http://jama.ama-assn.org/cgi/content/extract/299/9/1060
HSL13150
 Hampton T.
 Experts Debate Need to Improve Quality and Oversight of Continuing Education 
 JAMA 2008 Mar 5;299:(9):1003-1004
 
http://jama.ama-assn.org/cgi/content/extract/299/9/1003
HSL13151
 Waber RL, Shiv B, Carmon Z, Ariely D.
 Commercial Features of Placebo and Therapeutic Efficacy
 JAMA 2008 Mar 5;299:(9):1016-1017
 
http://jama.ama-assn.org/cgi/content/extract/299/9/1016
HSL13268
 Prescription Drug Advertisements Prompt One-Third Of U.S. Adults To Ask Their Physician About A Medication, Survey Finds
 Medical  News Today 2008 Mar 5
 
http://www.medicalnewstoday.com/articles/99463.php
HSL12957
 Vioxx Settlement on Track as 44,000 Sign Up 
 Associated Press 2008 Mar 4
 
http://www.nytimes.com/2008/03/04/business/04vioxx.html?_r=1&ei=5088&en=1675f4812ea9afab&ex=1362373200
HSL12962
  Greenhouse L.
 Court Allows Suit Against Drug Maker
 New York Times 2008 Mar 4
 
http://www.nytimes.com/2008/03/04/washington/04scotus.html?ref=health
HSL12976
  Woolhouse M.
 Ban on gifts to doctors sought
 The Boston Globe 2008 Mar 4
 
http://www.boston.com/news/health/articles/2008/03/04/ban_on_gifts_to_doctors_sought/?page=1
HSL12980
  Appleby J.
 As drug ads surge, more get Rx's filled 
 USA Today 2008 Mar 4
 
http://www.usatoday.com/news/health/2008-02-29-drugs-main_N.htm
HSL12986
 USA Today/Kaiser Family Foundation/Harvard School of Public Health Survey: The Public on Prescription Drugs and Pharmaceutical Companies
 USA Today/Kaiser Family Foundation/Harvard School of Public Health 2008 Mar 4
 
http://www.kff.org/kaiserpolls/pomr030408pkg.cfm
HSL13003
  Perrone M.
 FDA's review process under investigation
 Associated Press 2008 Mar 4
 
http://www.businessweek.com/ap/financialnews/D8V6OQH80.htm
HSL13008
  Zuger A.
 Drug Pitchmen: Actor, Doctor or Pfizer’s Option
  New York Times 2008 Mar 4
 
http://www.nytimes.com/2008/03/04/health/views/04essa.html?_r=1&th&emc=th&oref=slogin
HSL13062
 Dixon K, Richwine L.
 Flu drug makers change labels over behavior issue
 The Guardian 2008 Mar 4
 
http://www.guardian.co.uk/feedarticle?id=7357922
HSL13073
 Brandes L.
 Do some vitamins actually increase cancer risk?
 Med News Express, CTV.ca 2008 Mar 4
 
http://healthblog.ctv.ca/blog/_archives/2008/3/4/3558651.html
HSL13076
 Tanner L.
 Hormone use linked to cancer risks 
 American Broadcasting Company 2008 Mar 4
 
http://abcnews.go.com/Health/wireStory?id=4386987
HSL13078
 Allergan receives subpoena on promotional practices of Botox
 Pharmaceutical Business Review 2008 Mar 4
 
http://www.pharmaceutical-business-review.com/article_news.asp?guid=EC1DE9B7-2853-487F-A743-73FC6EE258D9
HSL13081
 Cassels A.
 Spreading disease by word of mouth: A is for Archie with AMDD and B is for Ben who has Bad Boy Behaviour
 Toronto Star 2008 Mar 4
 
http://www.thestar.com/article/308921
HSL13233
  Mark R.
 Network Intelligence is becoming a key enabler of commercial strategy
 eyeforpharma 2008 Mar 4
 
http://social.eyeforpharma.com/blogs/robert-mark/network-intelligence-becoming-key-enabler-commercial-strategy
HSL12978
  Leblanc S.
 Senate president unveils plan to control health care costs
 Associated Press 2008 Mar 3
 
http://www.boston.com/news/local/massachusetts/articles/2008/03/03/senate_president_unveils_plan_to_control_health_care_costs/
HSL13005
  Sarnsamak P.
 No cancellation of CL for cancer drugs : Chaiya
 The Nation (Bangkok) 2008 Mar 3
 
http://nationmultimedia.com/2008/03/03/national/national_30067110.php
HSL13017
  Hansell S.
 This Blood Test Is Brought to You by…
 New York Times 2008 Mar 3
 
http://bits.blogs.nytimes.com/2008/03/03/this-blood-test-is-brought-to-you-by/
HSL13074
 Bright B.
 Many Americans Recognize Risks Of Prescription Drugs, Polls Finds
 The Wall Street Journal 2008 Mar 3
 
http://online.wsj.com/article/SB120421481516300105.html
HSL13106
 Fisher D.
 Product Liability Preemption Pullback
 Forbes 2008 Mar 3
 
http://www.forbes.com/2008/03/03/scotus-fda-torts-biz-healthcare-cz_df_0303s
HSL13107
 Sandburg B
 Supreme Court Reaches Tie Vote in FDA Preemption Case 
 2008 Mar 3
 
HSL13174
 Surgeon Payments Disclosure Bill Advances
 Integrity in Science Watch 2008 Mar 3
 
http://www.cspinet.org/integrity/watch/200803031.html#2
HSL13231
 Media Perpetuates Unsubstantiated Chemical Imbalance Theory Of Depression, Study Shows
 ScienceDaily 2008 Mar 3
 
http://www.sciencedaily.com/releases/2008/03/080303164507.htm
HSL12938
  Revill J.
 Drug firms pressed on secret pill data
 The Observer (Guardian) 2008 Mar 2News p. 2
 
http://www.guardian.co.uk/society/2008/mar/02/mentalhealth.medicalresearch
HSL12960
  Raffaele M.
 State prescription-aid programs try to beat drug reps at own game
 Associated Press 2008 Mar 2
 
http://www.philly.com/philly/wires/ap/news/state/pennsylvania/20080302_ap_stateprescriptionaidprogramstrytobeatdrugrepsatowngame.html
HSL13047
 Revill J.
 Drug firms pressed on secret pill data
 The Guardian 2008 Mar 2
 
http://www.guardian.co.uk/society/2008/mar/02/mentalhealth.medicalresearch
HSL13223
 Christie T.
 Reformers resist aggressive drug marketing tactics
 The Register-Guard 2008 Mar 2
 
http://www.registerguard.com/csp/cms/sites/dt.cms.support.viewStory.cls?cid=
HSL12972
 McLay J, Ross S.
 Medication errors caused by junior doctors.
 BMJ 2008 Mar 1;336:(7642):456
 
http://www.bmj.com/cgi/content/extract/336/7642/456?etoc
HSL12973
 Stossel TP.
 Has the hunt for conflicts of interest gone too far? Yes
 BMJ 2008 March 1;336:(7642):467
 
http://www.bmj.com/cgi/content/full/336/7642/476?etoc
HSL12974
 Lee K.
 Has the hunt for conflicts of interest gone too far? No.
 BMJ 2008 Mar 1;336:(7642):477
 
http://www.bmj.com/cgi/content/full/336/7642/477?etoc
HSL12977
 Sokol DK.
 The dilemma of authorship.
 BMJ 2008 Mar 1;336:(7642):478
 
http://www.bmj.com/cgi/content/extract/336/7642/478?etoc
HSL12979
 Fitzpatrick M.
 From hero to zero.
 BMJ 2008 Mar 1;336:(7642):479
 
http://www.bmj.com/cgi/content/extract/336/7642/479?etoc
HSL12981
 Fahrenkopf AM, Sectish TC, Barger LK, Sharek PJ, Lewin D, Chiang VW, Edwards S, Wiedermann BL, Landrigan CP.
 Rates of medication errors among depressed and burnt out residents: prospective cohort study.
 BMJ 2008 Mar 1;336:(7642):488-491
 
http://www.bmj.com/cgi/content/abstract/336/7642/488?etoc
HSL12983
 Iheanacho I.
 We're all pharmacologists now.
 BMJ 2008 Mar 1;336:(7642):510
 
http://www.bmj.com/cgi/content/extract/336/7642/510-a?etoc/
HSL13234
  Perry S.
 The changes to come: evolutions in pharma
 eyeforpharma 2008 Mar 1
 
http://social.eyeforpharma.com/content/pharma-strategy/changes-come-evolutions-pharma
HSL13235
  Perry S.
 Aligning objectives: how to cover your clients without losing your shirt
 eyeforpharma 2008 Mar 1
 
http://social.eyeforpharma.com/content/pharma-strategy/aligning-objectives-how-cover-your-clients-without-losing-your-shirt
HSL13465
  Hosansky T.
 Fast-Track CME Reform 
 Medical Meetings 2008 Mar 1
 
http://meetingsnet.com/medicalmeetings/mag/meetings_fasttrack_cme_reform/index.html
HSL12869
 Munro G, de Wever J.
 Culture clash: alcohol marketing and public health aspirations.
 
Drug Alcohol Rev 2008 Mar;27:(2):204-11
 
http://www.informaworld.com/smpp/content?content=10.1080/09595230701827136
HSL12870
 Lutsenko H, Doran CM, Hall WD.
 Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
 
Drug Alcohol Rev 2008 Mar;27:(2):160-4
 
http://www.informaworld.com/smpp/content?content=10.1080/09595230701829462
HSL12915
 Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA.
 National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
 
J Pediatr 2008 Mar;152:(3):416-21
 
http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(07)00703-2
HSL12958
 Geier DA, King PG, Sykes LK, Geier MR.
 RotaTeq vaccine adverse events and policy considerations.
 Med Sci Monit 2008 Mar;14:(3):PH9-16
 
http://www.medscimonit.com/fulltxt.php?ICID=836566
HSL12959
 Babor TF, Xuan Z, Proctor D.
 Reliability of a rating procedure to monitor industry self-regulation codes governing alcohol advertising content.
 J Stud Alcohol Drugs. 2008 Mar;69:(2):235-42
 
http://www.ncbi.nlm.nih.gov/pubmed/18299764
HSL13001
  Othman N.
 Promosi ubat-ubatan: Adakah keuntungan mengaburi kualiti informasi? [Pharmaceutical promotion: Does the drive for profits reduce the quality of information?]
 Dewan Kosmik 2008 Mar25-26
 
HSL13053
 Cassels A.
 Statins awful side effects
 Common Ground 2008 Mar
 
http://commonground.ca/iss/200/cg200_cassels.shtml
HSL13056
 Shaw A.
 Direct-to-Consumer Advertising (DTC) of Pharmaceuticals
 ProQuest Discovery Guides 2008 Mar;
 
http://www.csa.com/discoveryguides/direct/review.php
HSL13100
 Smith JJ, Henderson JA.
 Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
 
J Am Coll Radiol 2008 Mar;5:(3):189-92
 
http://www.ncbi.nlm.nih.gov/pubmed/18312966
HSL13165
 Woo J, Wolfgang S, Batista H.
 The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
 
Clin Pharmacol Ther 2008 Mar;83:(3):494-7
 
http://www.nature.com/clpt/journal/v83/n3/abs/6100493a.html
HSL13180
 Baker D
 The Benefits and Savings of Publicly-Funded Clinical Trials of Prescription Drugs
 Washington, DC: Center for Economic and Policy Research 2008 Mar
 
http://www.cepr.net/documents/publications/clinicaltrials_2008_03.pdf
HSL13252
 Long SS.
 Off-label use and evidence of efficacy and safety for drugs in a tertiary-care neonatal intensive care unit.
 
J Pediatr 2008 Mar;152:(3):A2
 
http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(08)00016-4
HSL13379
 Luce BR, Paramore LC, Parasuraman B, Liljas B, de Lissovoy G.
 Can managed care organizations partner with manufacturers for comparative effectiveness research?
 
Am J Manag Care 2008 Mar;14:(3):149-56
 
http://www.ajmc.com/article.cfm?ID=10069&CFID=10776678&CFTOKEN=50788056
HSL13382
 Morrison MA, Krugman DM, Park P.
 Under the radar: smokeless tobacco advertising in magazines with substantial youth readership.
 
Am J Public Health 2008 Mar;98:(3):543-8
 
http://www.ajph.org/cgi/content/abstract/98/3/543
HSL13391
 Parikh RK.
 Fighting for the Reputation of Vaccines: Lessons From American Politics
 Pediatrics 2008 Mar;121:(3):621-622
 
http://pediatrics.aappublications.org/cgi/content/full/121/3/621
HSL13439
 Erlen JA.
 Conflict of Interest: Nurses at Risk!
 Orthop Nurs. 2008 Mar;27:(2):135-139
 
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00006416-200803000-00012
HSL13484
 Russo M
 Playing by Their Own Rules: An Analysis of Drug Company Gifts to Doctors
 Sacramento, CA: California Public Interest Research Group 2008 Mar
 
http://calpirg.org/uploads/kT/xD/kTxDYzgJx0_qqnKGr1pfgw/playing-by-their-own-rules.pdf
HSL13507
 Advertising complaint - Actos (pioglitazone) - healthcare professional advertisement - January 2008
 MHRA 2008 Mar
 
http://www.mhra.gov.uk/Howweregulate/Medicines/Advertisingofmedicines/Advertisinginvestigations/CON014509
HSL13561
 American College of Obstetricians and Gynecologists Committee on Ethics.
 ACOG Committee Opinion No. 401: Relationships with industry
 Obstet Gynecol. 2008 March;111:(3):799-804
 
http://www.greenjournal.org/cgi/reprint/111/3/799
HSL13562
 Samji HA, Jackler RK.
 'Not one single case of throat irritation': misuse of the image of the otolaryngologist in cigarette advertising.
 Laryngoscope 2008 Mar;118:(3):415-27
 
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/MLG.0b013e31815ad5c6
HSL13563
 Rowland D, Cooper S, Macias L.
 Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation.
 Int J Impot Res. 2008 Mar-Apr;20:(2):115-20
 
http://www.nature.com/ijir/journal/v20/n2/abs/3901559a.html;jsessionid=1A7DA59E195B52F462F4B4C84D67AA9F
HSL13631
 Friedman JH.
 My ties to big pharma.
 
Med Health R I 2008 Mar;91:(3):70-1
 
http://www.rimed.org/pdf/mhri/m08Marmhri.pdf
HSL13720
 Wallace LS, Keenum AJ, Roskos SE, Blake GH, Colwell ST, Weiss BD.
 Suitability and readability of consumer medical information accompanying prescription medication samples.
 
Patient Educ Couns 2008 Mar;70:(3):420-5
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-4RTKXF9-7&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3dec254566dd1c6ea376c7c50132a2b1
HSL13745
 Snyder L, Mueller PS.
 Research in the physician's office: navigating the ethical minefield.
 
Hastings Cent Rep 2008 Mar-Apr;38:(2):23-5
 
http://www.thehastingscenter.org/publications/hcr/hcr.asp
HSL13746
 Gilbert S.
 Trials and tribulations.
 
Hastings Cent Rep 2008 Mar-Apr;38:(2):14-8
 
http://www.thehastingscenter.org/publications/hcr/hcr.asp
HSL13751
 Sismondo S.
 Pharmaceutical company funding and its consequences: a qualitative systematic review.
 
Contemp Clin Trials 2008 Mar;29:(2):109-13
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7P72-4PF6B7P-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=2a2f21cc6118f01cfc316093753a989b
HSL13787
 American College of Clinical Pharmacy, Hatton RC, Chavez ML, Jackson E, Maurey J, Barriere SL, Couchenour R, Evens RP, Gunning K, Hume AL, Hutchison LC, Matzke GR, Noviasky JA, Rospond RM, Kelloway JS, Stevenson JG, Vanderveen RP, Verme-Gibboney CN, Walte
 Pharmacists and industry: guidelines for ethical interactions.
 
Pharmacotherapy 2008 Mar;28:(3):410-20
 
http://www.atypon-link.com/doi/abs/10.1592/phco.28.3.410
HSL13788
 Montague BT, Fortin AH 6th, Rosenbaum J.
 A systematic review of curricula on relationships between residents and the pharmaceutical industry.
 
Med Educ 2008 Mar;42:(3):301-8
 
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2923.2007.02998.x
HSL13804
 Geransar R, Einsiedel E.
 Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware?
 Genet Test. 2008 Mar;12:(1):13-23
 
http://www.liebertonline.com/doi/abs/10.1089/gte.2007.0024
HSL13840
 Cook JM, Weingardt KR, Jaszka J, Wiesner M.
 A content analysis of advertisements for psychotherapy workshops: implications for disseminating empirically supported treatments.
  J Clin Psychol 2008 Mar;64:(3):296-307
 
http://www3.interscience.wiley.com/journal/117909790/abstract?CRETRY=1&SRETRY=0
HSL13902
 GarcÃa-Alonso MD, GarcÃa-Mariñoso B.
 The strategic interaction between firms and formulary committees: effects on the prices of new drugs.
 J Health Econ 2008 Mar;27:(2):377-404
 
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8K-4R8HHNP-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=591ff51f314409b4bdd7bac4adbca31e
HSL14038
 Garattini L, Motterlini N, Cornago D.
 Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries.
 Health Policy. 2008 Mar;85:(3):305-13
 
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(07)00194-7
Page 59 of 206 pages ‹ First < 57 58 59 60 61 > Last ›
 








 


